Consensus Stryker Corporation

Stocks

SYK

US8636671013

Medical Equipment, Supplies & Distribution

Market Closed - NYSE 16:02:04 2026-10-16 EDT			5-day change	1st Jan Change
294.66 ^USD	+0.49%		+6.25%	-16.16%

10-14	Stryker Launches Sonopet 3, Delivering Greater Power And Precision In Ultrasonic Tissue Removal	CI
10-14	Stryker Receives FDA Clearance for Ultrasonic Tissue Removal Platform	MT

Evolution of the Average Target: Stryker Corporation

Evolution of the Target Price: Stryker Corporation

Changes in Analyst Recommendations: Stryker Corporation

7b.QR-hXA4dnYKzXEr3bM68FXsS_QBaBbX5eQdpZzEl1Jw.DCmMF0ty2rrYGXiSNIXpSilnl3keR--MPEErA39rn_EjdMkbb2n77IoUIQ~7150e1f25f34cf6b84098a0e204e5fd2

Analysts' recommendations: Stryker Corporation

10-12	BTIG Adjusts Price Target on Stryker to $316 From $358	MT
10-09	Leerink Partners Adjusts Stryker Price Target to $353 From $403	MT
10-06	Truist Securities Cuts Stryker Price Target to $310 From $340, Maintains Hold Rating	MT
10-06	Evercore ISI Adjusts Price Target on Stryker to $335 From $355, Keeps Outperform Rating	MT
10-06	Evercore ISI Adjusts Stryker Price Target to $335 From $355, Maintains Outperform Rating	MT
09-30	Stifel Adjusts Price Target on Stryker to $330 From $360, Maintains Buy Rating	MT
09-22	TD Cowen Adjusts Price Target on Stryker to $298 From $355, Keeps Hold Rating	MT
09-22	Jefferies Adjusts Price Target on Stryker to $405 From $440, Keeps Buy Rating	MT
09-21	Raymond James Adjusts Price Target on Stryker to $330 From $370, Keeps Outperform Rating	MT
09-18	Canaccord Genuity Adjusts Price Target on Stryker to $385 From $400, Keeps Buy Rating	MT
09-17	Stryker Facing Promising Setup Next Year, Trading Upside Limited in 2026, RBC Says	MT
09-14	Bernstein Adjusts Price Target on Stryker to $385 From $420, Keeps Outperform Rating	MT
09-09	Citigroup Adjusts Stryker Price Target to $360 From $399, Maintains Buy Rating	MT
09-09	Wells Fargo Adjusts Price Target on Stryker to $348 From $418, Keeps Overweight Rating	MT
09-09	BMO Capital Adjusts Price Target on Stryker to $317 From $369, Keeps Outperform Rating	MT
08-18	Leerink Partners Adjusts Price Target on Stryker to $403 From $407, Maintains Outperform Rating	MT
08-13	Citigroup Adjusts Price Target on Stryker to $399 From $385, Maintains Buy Rating	MT
08-05	Rothschild & Co Redburn Adjusts Stryker Price Target to $360 From $346	MT
08-03	UBS Adjusts Stryker Price Target to $382 From $400, Maintains Buy Rating	MT
08-03	Analyst recommendations: Chevron, Linde, RTX, Colgate-Palmolive, American Electric Power...
07-31	RBC Cuts Price Target on Stryker to $420 From $435, Keeps Outperform Rating	MT
07-31	Evercore ISI Adjusts Stryker Price Target to $355 From $350, Maintains Outperform Rating	MT
07-31	Truist Lifts Price Target on Stryker to $340 From $330, Keeps Hold Rating	MT
07-31	Raymond James Adjusts Price Target on Stryker to $370 From $383, Maintains Outperform Rating	MT
07-31	Jefferies Adjusts Price Target on Stryker to $440 From $455, Maintains Buy Rating	MT

More recommendations

Medical Devices & Implants

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	STRYKER CORPORATION					+23.06%
	ABBOTT LABORATORIES					+15.09%
	MEDTRONIC PLC					+10.41%
	ESSILORLUXOTTICA					+43.42%
	CENCORA, INC.					+7.85%
	HOYA CORPORATION					+16.96%
	BECTON, DICKINSON AND COMPANY					+1.21%
	IDEXX LABORATORIES, INC.					+25.9%
	DEXCOM, INC.					+12.11%
	ALCON INC.					+36.63%
	Average					+19.26%
	Weighted average by Cap.					+18.46%